119 results
8-K
EX-10.2
zsni2d5x thdsut
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
D
39r8j484
14 Nov 22
$7.00 mm in equity / options / securities to be acquired, sold $7.00 mm, 6 investors
4:51pm
8-K
EX-10.1
a5tmiuu6bfivj7ko
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
D
vedan9 tx6k6wmzn5eff
17 Oct 22
$7.00 mm in equity / options / securities to be acquired, sold $7.00 mm, 6 investors
4:36pm
8-K
EX-10.1
vn67uo3q8ore
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
D
qnc53d7pyey4lchnm9
15 Aug 22
$15M in equity / options / securities to be acquired, sold $15M, 6 investors
8:08pm
8-K
EX-10.1
eshys3
1 Aug 22
TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital
6:55am
SC 14D9
i4zjbnb 0v30jk5vja
10 Jun 22
Tender offer solicitation
6:51pm
SC TO-T
EX-99
tufp79opm2o
6 Jun 22
Third party tender offer statement
5:02pm
8-K
EX-10.2
kfj6hojq
31 May 22
TherapeuticsMD and EW Healthcare Partners
6:47am
8-K
EX-2.1
qa8cxxsir0j1e3
31 May 22
TherapeuticsMD and EW Healthcare Partners
6:47am
8-K
EX-2.1
x1tk5
10 Mar 22
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
7:15am